| Ytd | -97.56% | |
| 1y | -99.14% |
| Open | 1.43 | Prev Close | 1.42 | Low | 1.42 | High | 1.55 | Mkt Cap | 137.15K |
| Vol | 409.05K | Avg Vol | 2.97M | EPS | -2.28 | P/E | -0.65 | Forward P/E | -0.41 |
| Beta | 0.31 | Short Ratio | 0.26 | Inst. Own | 1.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 5.02 | 200-d Avg | 50.84 | 1yr Est | 16.00 |
MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for pa
Development initiatives to strategically extend Aquadex® platform capabilities for future immunomodu
Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular sessio
US stocks rise, Nasdaq up 300 points. Dow up 0.36%, Nasdaq up 1.31%, S&P 500 up 0.65%. Amazon sh
Nuwellis also received $3.1 Million from the Exercise of Previously Issued Warrants from the June 20
Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-
Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pr
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's
Nuwellis shares are surging Thursday afternoon as traders react to new pediatric data tied to the co
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular
US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%,
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for pa
Peer-reviewed research demonstrates epoprostenol maintained circuit performance without observed ble
Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares
Nuwellis shares surged 89.97% after hours following recent pediatric hospital expansion and strong p
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
Management expects to report its financial results for the three and six months ended June 30, 2026,
Company expects preliminary revenue year-over-year growth of 14% for second quarter 2026 and 20% for
Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regula
Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday'
Innovation enables customizable catheter length while maintaining structural integrity during ultraf
https://ppubs.uspto.gov/api/pdf/downloadPdf/US-12678592-B2?source=USPAT&requestToken=eyJzdWIiOiJ
MINNEAPOLIS, July 07, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
MINNEAPOLIS, June 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
MINNEAPOLIS, June 25, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
MINNEAPOLIS, June 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark
MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
Transition to become effective June 30, 2026; current CEO John Erb to continue as Chairman of the Bo
South Carolina healthcare provider also upgrades to latest Aquadex devices at its two locations that
MINNEAPOLIS , June 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology
href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in
MINNEAPOLIS, June 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology c
Proposal would extend treatment access to pediatric patients weighing 5 kg and above Proposal would
Nuwellis, Inc. (NUWE) Q1 2026 Earnings Call Transcript
MINNEAPOLIS, May 12, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology co
MINNEAPOLIS, May 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology co